Clinical Trial Update: A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for DE-111A in open-angle glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocallular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-111A

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED